|
Most of it is still with adult, umbilical cord, or fetal stem cells--all of which were funded well enough before 1/09, of course.
There was a fair amount of embryonic stem cell research going on before 1/09, as well, just not as much. There were some administrative hurdles that made such research much more expensive than it needed to be, as well.
A lot of people overlooked that there are different kinds of stem cells, and others ignored that ESC research was going on under *. It was sadly inconvenient, on so many levels. The result is that they trumpet the ESC research, as something new; and they still overlook the non-ESC research that was and is being done. Or, worse, they assume that such research was only being done because the "good" ESC research couldn't be done or was even illegal. Details should matter.
However, the increased volume of ESC research will take a while to ramp up. IIRC, they're still dealing with some basic problems in using ESCs. These are two of the reasons that a relatively small amount of the California stem-cell research money went to ESC this year. I think there may be a few ESC treatments getting close to clinical trials, but I'm not going to commit to that. That there are more non-ESC SC treatments getting close to clinical trials is still true.
Meanwhile, they keep finding new ways to use non-ESC stem cells. IIRC, they've even managed to make adult cells (not stem cells) into fully pluripotent stem cells, but that may have been in mice.
The technology is pretty much not there.
|